Epidemiologic data of primary glomerular diseases in western France, Kidney International, vol.66, issue.3, pp.905-908, 2004. ,
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, The Lancet, vol.385, issue.9981, pp.1983-1992, 2015. ,
M-type phospholipase A 2 receptor as target antigen in idiopathic membranous nephropathy, The New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00417718
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, The New England Journal of Medicine, vol.371, issue.24, pp.2277-2287, 2014. ,
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy, Kidney International, vol.95, issue.3, pp.666-679, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02380896
Prognosis of untreated patients with idiopathic membranous nephropathy, The New England Journal of Medicine, vol.329, issue.2, pp.85-89, 1993. ,
Treatment of idiopathic membranous nephropathy, Nature Reviews Nephrology, vol.9, issue.8, pp.443-458, 2013. ,
Rituximab in idiopathic membranous nephropathy, Journal of the American Society of Nephrology, vol.23, issue.8, pp.1416-1425, 2012. ,
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)-lines-application to the individual patient, Kidney International, vol.82, issue.8, pp.840-856, 2012. ,
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney International, vol.95, issue.2, pp.268-280, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02380922
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, The Journal of Clinical Investigation, vol.126, issue.7, pp.2519-2532, 2016. ,
Anti-phospholipase A 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy, Clinical journal of the American Society of Nephrology, vol.6, issue.6, pp.1286-1291, 2011. ,
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients, Dialysis, Transplantation, vol.29, issue.12, pp.2334-2342, 2014. ,
Anti-phospholipase A 2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy, Journal of the American Society of Nephrology, vol.26, issue.10, pp.2545-2558, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02193793
Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy, Journal of the American Society of Nephrology, vol.27, issue.5, pp.1517-1533, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455661
Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy, Journal of the American Society of Nephrology, vol.29, issue.2, pp.401-408, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02193807
High-dose rituximab and early remission in PLA2R1-related membranous nephropathy, Clinical Journal of the American Society of Nephrology, vol.14, issue.8, pp.1173-1182, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02413171
Does epitope spreading influence responsiveness to rituximab in PLA2R-associated membranous 12 Journal of Immunology Research nephropathy?, Clinical Journal of the American Society of Nephrology, vol.14, issue.8, pp.1122-1124, 2019. ,
Complement. First of two parts, The New England Journal of Medicine, vol.344, issue.14, pp.1058-1066, 2001. ,
Structural insight into proteolytic activation and regulation of the complement system, Immunological Reviews, vol.274, issue.1, pp.59-73, 2016. ,
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals, The Journal of Clinical Investigation, vol.66, issue.1, pp.71-81, 1980. ,
Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy, The Journal of Clinical Investigation, vol.77, issue.4, pp.1096-1107, 1986. ,
Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy, Internal Medicine, vol.41, issue.11, pp.936-942, 2002. ,
Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy, Nephrology, Dialysis, Transplantation, vol.19, issue.3, pp.574-579, 2004. ,
IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression, Modern Pathology, vol.26, issue.6, pp.799-805, 2013. ,
Inhibition of complement activation by IgG4 antibodies, Clinical and Experimental Immunology, vol.64, issue.2, pp.415-422, 1986. ,
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain, The Journal of Experimental Medicine, vol.173, issue.4, pp.1025-1028, 1991. ,
Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese, Clinical and Experimental Nephrology, vol.19, issue.5, pp.797-803, 2015. ,
Glomerular mannosebinding lectin deposition in intrinsic antigen-related membranous nephropathy, Nephrology, Dialysis, Transplantation, vol.33, issue.5, pp.832-840, 2018. ,
Phospholipase A2 receptor-related membranous nephropathy and mannanbinding lectin deficiency, Journal of the American Society of Nephrology, vol.27, issue.12, pp.3539-3544, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02180286
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy, Clinica Chimica Acta, vol.421, pp.213-218, 2013. ,
Microdroplet assay of human serum cytotoxins, Nature, vol.204, issue.4962, pp.998-1000, 1964. ,
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease, Journal of Biological Chemistry, vol.288, issue.51, pp.36598-36609, 2013. ,
Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy, Biochimie, vol.118, pp.104-115, 2015. ,
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy, Journal of the American Society of Nephrology, vol.23, issue.10, pp.1735-1743, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00919117
Antigen-specific IgG subclasses in primary and malignancyassociated membranous nephropathy, Frontiers in Immunology, vol.9, p.3035, 2018. ,
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus, The Journal of Investigative Dermatology, vol.120, issue.1, pp.1-5, 2003. ,
Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic purpura, Frontiers in Immunology, vol.9, p.1646, 2018. ,
Factor H autoantibodies and membranous nephropathy, The New England Journal of Medicine, vol.379, issue.25, pp.2479-2481, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02193814
IgG subclasses and complement pathway in segmental and global membranous nephropathy, Pediatric Nephrology, vol.25, issue.6, pp.1091-1099, 2010. ,
Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies, Kidney International, vol.87, issue.3, pp.602-609, 2015. ,
Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy, Frontiers in Immunology, vol.9, p.1433, 2018. ,
Human antithrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway, Bioscience Reports, vol.38, issue.3, 2018. ,
A heterologous model of thrombospondin type 1 domaincontaining 7A-associated membranous nephropathy, Journal of the American Society of Nephrology, vol.28, issue.11, pp.3262-3277, 2017. ,
Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2, Biochemistry, vol.34, issue.40, pp.13146-13151, 1995. ,
Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen, European Journal of Clinical Investigation, vol.44, issue.8, pp.753-765, 2014. ,
C-type lectinlike domain and fibronectin-like type II domain of 13 Journal of Immunology Research phospholipase A 2 receptor 1 modulate binding and migratory responses to collagen, FEBS Letters, vol.589, issue.7, pp.829-835, 2015. ,
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, The New England Journal of Medicine, vol.372, issue.11, pp.1073-1075, 2015. ,
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, The New England Journal of Medicine, vol.372, issue.11, pp.1073-1075, 2015. ,
A new classification system for IgG4 autoantibodies, Journal of Immunology Research, vol.9, issue.14, p.97, 2018. ,